市場調査レポート
商品コード
1123121

ウシ胎児血清(FBS)の世界市場:2022年~2028年

Global Fetal Bovine Serum Market Research and Forecast 2022-2028

出版日: | 発行: Orion Market Research | ページ情報: 英文 131 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
ウシ胎児血清(FBS)の世界市場:2022年~2028年
出版日: 2022年07月22日
発行: Orion Market Research
ページ情報: 英文 131 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のウシ胎児血清(FBS)の市場規模は、予測期間中に相当なCAGRで拡大すると予測されています。

市場の成長は、創薬や研究開発において、基礎研究から特殊アッセイまで、ウシ胎児血清(FBS)の幅広い需要があることに起因しています。さらに、理想的な細胞増殖補助剤として細胞培養における需要が大きく、他の種類の細胞培養用血清よりも嗜好性が高まっていることも、市場の成長を後押ししています。新薬の研究開発活動の増加、バイオ医薬品業界の拡大、政府からの投資・資金調達の増加も、ウシ胎児血清(FBS)市場の成長に重要な役割を果たしています。

当レポートでは、世界のウシ胎児血清(FBS)市場について調査し、市場の概要とともに、競合情勢、セグメント別の動向、地域別分析、および企業プロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストによる洞察と現在の市場動向
  • 規制

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の展開
  • 主要戦略分析

第4章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場セグメンテーション

  • 世界のウシ胎児血清(FBS)市場:製品タイプ別
    • 活性炭処理済み
    • クロマトグラフ
    • 透析処理済みウシ胎児血清(FBS)
    • 幹細胞
    • その他(エクソソーム除去)
  • 世界のウシ胎児血清(FBS)市場:エンドユーザー別
    • バイオ製品・製薬会社
    • 研究所
    • 学術研究機関
    • その他(セルバンク)
  • 世界のウシ胎児血清(FBS)市場:用途別
    • 産業研究
    • 科学研究

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • ASEAN
    • その他アジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第7章 企業プロファイル

  • Access Biologicals LLC
  • Animal Technologies, Inc.
  • Atlanta Biologicals (R&D Systems, Inc.)
  • Axil Scientific Pte Ltd
  • Biological Industries Ltd.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd.
  • Corning Inc.
  • Cytiva
  • ExCell Biotech Co., Ltd.
  • General Electric Co.
  • HiMedia Laboratories
  • Life Technologies (India) Pvt Ltd
  • Merck KGaA
  • Moregate Biotech
  • Nucleus Biologics
  • PAN-Biotech GmbH
  • Rocky Mountain Biologicals, Inc.
  • Thermo Fisher Scientific Inc.
  • Tissue Culture Biologicals
  • TCS Biosciences Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL CHARCOAL STRIPPED FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL CHROMATOGRAPHIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL DIALYZED FBS FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL STEM CELL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL OTHERS FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 8. GLOBAL FETAL BOVINE SERUM FOR BIOPRODUCT & PHARMACEUTICAL COMPANY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL FETAL BOVINE SERUM FOR RESEARCH LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL FETAL BOVINE SERUM FOR ACADEMIC INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL FETAL BOVINE SERUM FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 13. GLOBAL FETAL BOVINE SERUM IN INDUSTRIAL RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL FETAL BOVINE SERUM IN SCIENTIFIC RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)
  • 20. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 22. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 23. EUROPEAN FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 26. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 27. ASIA-PACIFIC FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)
  • 28. REST OF THE WORLD FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 30. REST OF THE WORLD FETAL BOVINE SERUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-20272020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 3. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 4. GLOBAL FETAL BOVINE SERUM MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. GLOBAL CHARCOAL STRIPPED FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 6. GLOBAL CHROMATOGRAPHIC FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL DIALYZED FBS FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL STEM CELL FETAL BOVINE SERUM MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL FETAL BOVINE SERUM FOR BIOPRODUCT & PHARMACEUTICAL COMPANY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL FETAL BOVINE SERUM FOR RESEARCH LABORATORY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL FETAL BOVINE SERUM FOR ACADEMIC INSTITUTE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL FETAL BOVINE SERUM FOR OTHERS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL FETAL BOVINE SERUM IN INDUSTRIAL RESEARCH MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL FETAL BOVINE SERUM IN SCIENTIFIC RESEARCH MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. US FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. CANADA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. UK FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. FRANCE FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. GERMANY FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. ITALY FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. SPAIN FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. REST OF EUROPE FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. INDIA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. CHINA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. JAPAN FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. SOUTH KOREA FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. ASEAN FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD FETAL BOVINE SERUM MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2017244

Global Fetal Bovine Serum Market Size, Share & Trends Analysis Report by Product Type (Charcoal Stripped, Chromatographic, Dialyzed FBS, Stem Cell, and Others) By End-User (Bioproduct & Pharmaceutical Companies, Research Laboratories, Academic Institutes, and Others) By Application (Industrial Research and Research and Scientific Research) Forecast 2021-2027

The global market for fetal bovine serum is projected to have a considerable CAGR during the forecast period. Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin, and clotting factors, but containing a large number of nutritional and macro-molecular factors essential for cell growth. Bovine serum albumin is the major component of FBS. Growth factors in FBS are essential for the maintenance and growth of cultured cells. FBS also contains a variety of small molecules such as amino acids, sugars, lipids, and hormones.

The market growth is driven by extensive demand for fetal bovine serum in drug discovery and R&D, from basic research to specialty assays. Besides, its significant demand in cell culture as an ideal cell growth supplement and growing preference over other types of cell culture sera is also fueling the growth of the market. There are a variety of fetal bovine serum grades including standard and specialty grades available in the market based on application. The increasing R&D activities for novel drugs, expansion of bio-pharmaceutical industries, and increase in investment and funding from the government also play a significant role in the growth of the fetal bovine serum market.

However, the ethical and scientific concerns associated with the potential misuse of biotechnology research practices and the shortfall of skilled personnel hinder the fetal bovine serum market. The rapid advancement in R&D activities and new drug developments by private and government sectors are expected to offer lucrative growth opportunities in the global fetal bovine serum market.

Segmental Outlook

The global Fetal Bovine Serum market is segmented into product type and end-user. On the basis of product type, the market is sub-segmented into charcoal-stripped, chromatographic, dialyzed FBS, stem cell, and others. Among these, the stem cell segment is expected to grow significantly owing to the adoption of these stem cells in various animal cell cultures. Based on end-user, the market is classified into bioproduct & pharmaceutical companies, research laboratories, academic institutes, and others. Similarly, by application, the fetal bovine serum market is categorized into industrial research and scientific research.

Global Fetal Bovine Serum Market Share by Application, 2020(%)

Global Fetal Bovine Serum Market Share by Application

The Cell Culture Maintenance Sub-Segment dominated the Fetal Bovine Serum Market.

Among, application, the cell culture maintenance sub-segment in scientific research held the major market share in 2020, and it is also expected to maintain its dominance in terms of growth during the forecast period. It is most widely used as a supplement during cell culture media exceeds cell culture testing standards to identify growth factors responsible for cultured cells. Thus, the use of fetal bovine serum in cell culture due to its high quantity of hormones, carrier proteins, and macro-molecular proteins to promote growth medium will lead to the growth of this segment which, in turn, further drives the market growth.

Regional Outlook

Geographically, the global Fetal Bovine Serum market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)).

Asia-Pacific is anticipated to grow at the highest CAGR owing to the growing demand for advanced healthcare facilities in emerging economies of the region. Additionally, the increasing focus of major market players towards the development of innovative products by collaborating with other market players in the region further provide ample opportunity to market.

Moreover, the increasing interest of the government and regulatory bodies towards stem cell research and development activities in emerging economies such as India and China are some other factors that are contributing to the growth of the fetal bovine serum market in Asia-Pacific. Apart from this, the infrastructural development and rise in outsourcing of research activities to the contract research organizations (CRO) coupled with low-cost fuels the market growth.

Global Fetal Bovine Serum Market Growth by Region, 2021-2027

Global Fetal Bovine Serum Market Share by region

North America held the major market share in the Fetal Bovine Serum market

Geographically, North America dominated the fetal bovine serum market in 2020, and is expected to grow continuously during the forecast period. The factors that drive the growth of the fetal bovine serum market in the region include the growing awareness about fetal bovine serums among the population and rising funding for R&D activities. North America has a well-developed healthcare infrastructure, owing to which, the companies invest largely in the development of an innovative platform for cell culture systems. North America is the largest market for manufacturing bio-pharmaceutical and laboratory products, hence create enormous opportunities for the fetal bovine serum market that drives the market in the region.

Market Players Outlook

Some of the key players in the fetal bovine serum market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market are Thermo Fisher Scientific Inc, General Electric, Merck KGaA, PAN-Biotech GmbH, HiMedia Laboratories, TCS Biosciences Ltd., Corning Inc., among others. To survive in the market, these market players adopt different marketing strategies such as mergers & acquisitions, R&D, product launches, and geographical expansions so on. For instance, in January 2019, Bio-Tech Corp., acquired Atlanta Biologicals based in Georgia specialized in the making of bovine-derived serum that promotes cell growth during the biotech experiment. With this acquisition, Bio-Tech Corp. has expanded its product portfolio in tissue-culture reagents with cell culture and tissue regeneration capabilities of Atlanta Biologicals in fetal bovine serum.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global Fetal Bovine Serum market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Fetal Bovine Serum Market By Product Type
    • 5.1.1. Charcoal Stripped
    • 5.1.2. Chromatographic
    • 5.1.3. Dialyzed FBS
    • 5.1.4. Stem Cell
    • 5.1.5. Others (Exosome Depleted)
  • 5.2. Global Fetal Bovine Serum Market By End-User
    • 5.2.1. Bioproduct & Pharmaceutical Company
    • 5.2.2. Research Laboratory
    • 5.2.3. Academic Institute
    • 5.2.4. Others (Cell Bank)
  • 5.3. Global Fetal Bovine Serum Market, By Application
    • 5.3.1. Industrial Research
      • 5.3.1.1. Antibody Production
      • 5.3.1.2. Veterinary Applications
    • 5.3.2. Scientific Research
      • 5.3.2.1. Cell Culture Maintenance
      • 5.3.2.2. Exosome Research
      • 5.3.2.3. Immunoassays Methods

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korean
    • 6.3.5. ASEAN
    • 6.3.6. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East Africa

7. Company Profiles

  • 7.1. Access Biologicals LLC
  • 7.2. Animal Technologies, Inc.
  • 7.3. Atlanta Biologicals (R&D Systems, Inc.)
  • 7.4. Axil Scientific Pte Ltd
  • 7.5. Biological Industries Ltd.
  • 7.6. Biowest SAS
  • 7.7. Bovogen Biologicals Pty Ltd.
  • 7.8. Corning Inc.
  • 7.9. Cytiva
  • 7.10. ExCell Biotech Co., Ltd.
  • 7.11. General Electric Co.
  • 7.12. HiMedia Laboratories
  • 7.13. Life Technologies (India) Pvt Ltd
  • 7.14. Merck KGaA
  • 7.15. Moregate Biotech
  • 7.16. Nucleus Biologics
  • 7.17. PAN-Biotech GmbH
  • 7.18. Rocky Mountain Biologicals, Inc.
  • 7.19. Thermo Fisher Scientific Inc.
  • 7.20. Tissue Culture Biologicals
  • 7.21. TCS Biosciences Ltd.